{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:18:42Z","timestamp":1793146722970,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Therapeutic hypothermia (TH) is the standard of care to improve outcomes following neonatal hypoxic-ischemic encephalopathy (HIE), but mortality and morbidity remain high, prompting research into treatment adjuncts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess whether erythropoietin (EPO) plus TH improves outcomes in infants with moderate or severe HIE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>The PAEAN (Preventing Adverse Outcomes of Neonatal Hypoxic Ischaemic Encephalopathy with Erythropoietin) study was a phase 3, multicenter, double-blinded, placebo-controlled randomized clinical trial conducted in 24 neonatal intensive care units in Australia, New Zealand, and Singapore. Infants 35 weeks\u2019 gestation or older, less than 23 hours old, with perinatal depression (umbilical cord arterial pH &amp;amp;lt;7.0 or base excess \u226512 mmol\/L or, at 10 minutes, Apgar score \u22645 or still receiving resuscitation), and moderate or severe HIE (modified Sarnat criteria) who had commenced TH within 6 hours of birth were eligible for inclusion. Study recruitment was conducted between May 2016 and March 2021, with data collection completed in September 2024. Data analysis was performed from September 2024 to October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Intravenous EPO, 1000 IU\/kg (5 doses over the first week), or placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was a composite of death or moderate or severe motor or cognitive disability using standardized neurological and developmental assessments at 2 years. Moderate or severe disability comprised motor deficit (diagnosis of cerebral palsy with Gross Motor Function Classification Scale score \u22652) or moderate or severe cognitive deficit using Bayley Scales of Infant Development, Third Edition. Secondary outcomes included death, disabilities alone, and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 2016 to 2021, 313 infants were randomized (EPO: n\u2009=\u2009156; placebo: n\u2009=\u2009157). Baseline characteristics (including mean [SD] gestational age at birth: 39.4 [1.7] weeks vs 39.3 [1.6] weeks and ratio of moderate:severe encephalopathy: 78%:22% vs 77%:23%) and loss to follow-up (10.2% overall) were similar across both groups. There were 67 (42.9%) and 59 (37.6%) female infants, respectively. There was no significant difference in the primary outcome (EPO: 47 of 138 [34.1%] vs placebo: 41 of 143 [28.7%]; relative risk, 1.19; 95% CI, 0.84-1.68;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.33), in secondary outcomes (death: 22 of 146 [15.1%] vs 18 of 149 [12.1%];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.45; cerebral palsy: 22 of 120 [18.3%] vs 22 of 127 [17.3%]; motor deficit: 13 of 120 [10.8%] vs 15 of 127 [11.8%]; cognitive deficit: 20 of 113 [17.7%] vs 16 of 118 [13.6%]), or in any safety outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Per the results of this multicenter randomized clinical trial, EPO did not demonstrate any adjunctive effect to hypothermia, but no safety concerns were evident.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      anzctr.org.au Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=366481&amp;amp;amp;isReview=true\">ACTRN12614000669695<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2026.3082","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:30:39Z","timestamp":1785166239000},"page":"1085","source":"Crossref","is-referenced-by-count":2,"title":["Erythropoietin for Neonatal Hypoxic-Ischemic Encephalopathy"],"prefix":"10.1001","volume":"180","author":[{"given":"Helen G.","family":"Liley","sequence":"first","affiliation":[{"name":"Mater Research Institute, University of Queensland, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod W.","family":"Hunt","sequence":"additional","affiliation":[{"name":"Monash Medical Centre and Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"O\u2019Connell","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm R.","family":"Battin","sequence":"additional","affiliation":[{"name":"Auckland City Hospital and The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Novak","sequence":"additional","affiliation":[{"name":"The University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne W.","family":"Wu","sequence":"additional","affiliation":[{"name":"The Cerebral Palsy Alliance Research Institute, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ballard","sequence":"additional","affiliation":[{"name":"The Cerebral Palsy Alliance Research Institute, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Askie","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Badawi","sequence":"additional","affiliation":[{"name":"The University of California, San Francisco"},{"name":"The Children\u2019s Hospital at Westmead, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Ghadge","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"The Royal Women\u2019s Hospital and University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Juul","sequence":"additional","affiliation":[{"name":"The University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Sebastian","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Wagh","sequence":"additional","affiliation":[{"name":"Mater Research Institute, University of Queensland, South Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. John","family":"Simes","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PAEAN Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Clough","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bowen","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Colditz","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girsih","family":"Deshpande","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Gold","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Hague","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Lui","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Austin","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bellhouse","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Berry","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Collins","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Dyson","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio G","family":"de Paoli","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert","family":"de Waal","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bevan","family":"Headley","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Hickey","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Holberton","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hou","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L","family":"Kent","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Kodur","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mausling","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Morris","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Nair","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Osborn","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Samuel","family":"Rajadurai","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Schmidt","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Tan","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B","family":"Tracy","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora Y","family":"Wong","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Finlayson","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Hunt","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carbo","family":"Yeung","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Ralston","sequence":"additional","affiliation":[{"name":"for the PAEAN Study Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"poi260044r1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41390-024-03303-3","article-title":"Consensus definition and diagnostic criteria for neonatal encephalopathy-study protocol for a real-time modified Delphi study.","volume":"97","author":"Branagan","year":"2025","journal-title":"Pediatr Res"},{"issue":"4","key":"poi260044r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2021.101265","article-title":"Neonatal encephalopathy: focus on epidemiology and underexplored aspects of etiology.","volume":"26","author":"McIntyre","year":"2021","journal-title":"Semin Fetal Neonatal Med"},{"issue":"7172","key":"poi260044r4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/bmj.317.7172.1554","article-title":"Intrapartum risk factors for newborn encephalopathy: the Western Australian case-control study.","volume":"317","author":"Badawi","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"poi260044r5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajog.2019.07.032","article-title":"The physiology of intrapartum fetal compromise at term.","volume":"222","author":"Turner","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"poi260044r6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s41591-024-02912-z","article-title":"Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy.","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"poi260044r7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003311.pub3","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy.","volume":"2013","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"poi260044r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2025.114793","article-title":"Therapeutic hypothermia in low- and middle-income countries: a systematic review and meta-analysis.","volume":"288","author":"Lee","year":"2026","journal-title":"J Pediatr"},{"issue":"9","key":"poi260044r9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/10985549.2025.2522720","article-title":"Hypoxia signaling in the cell type-specific regulation of erythropoietin production throughout mammalian development.","volume":"45","author":"Suzuki","year":"2025","journal-title":"Mol Cell Biol"},{"issue":"12","key":"poi260044r10","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.exphem.2008.08.003","article-title":"Erythropoietins: a common mechanism of action.","volume":"36","author":"Elliott","year":"2008","journal-title":"Exp Hematol"},{"issue":"11","key":"poi260044r11","doi-asserted-by":"publisher","first-page":"RA240","DOI":"10.12659\/MSM.882037","article-title":"Erythropoietin update 2011.","volume":"17","author":"Kowalczyk","year":"2011","journal-title":"Med Sci Monit"},{"issue":"4","key":"poi260044r12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00004647-200204000-00003","article-title":"Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain.","volume":"22","author":"Bernaudin","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"issue":"42","key":"poi260044r13","doi-asserted-by":"publisher","first-page":"39728","DOI":"10.1074\/jbc.M204619200","article-title":"Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. identification of genes that might contribute to hypoxia-induced ischemic tolerance.","volume":"277","author":"Bernaudin","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"poi260044r14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/antiox11040652","article-title":"Erythropoietin as a neuroprotective drug for newborn infants: ten years after the first use.","volume":"11","author":"Perrone","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"poi260044r15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s41390-019-0493-6","article-title":"Placental pathology and neonatal brain MRI in a randomized trial of erythropoietin for hypoxic-ischemic encephalopathy.","volume":"87","author":"Wu","year":"2020","journal-title":"Pediatr Res"},{"issue":"4","key":"poi260044r16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000486820","article-title":"High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): a randomized controlled trial - background, aims, and study protocol.","volume":"113","author":"Juul","year":"2018","journal-title":"Neonatology"},{"issue":"22","key":"poi260044r17","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2025.4347","article-title":"CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.","volume":"333","author":"Hopewell","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"poi260044r18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","article-title":"Development and reliability of a system to classify gross motor function in children with cerebral palsy.","volume":"39","author":"Palisano","year":"1997","journal-title":"Dev Med Child Neurol"},{"issue":"2 Pt 1","key":"poi260044r19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0022-3476(99)70016-8","article-title":"Optimality score for the neurologic examination of the infant at 12 and 18 months of age.","volume":"135","author":"Haataja","year":"1999","journal-title":"J Pediatr"},{"issue":"6","key":"poi260044r20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0191","article-title":"High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a phase II trial.","volume":"137","author":"Wu","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"poi260044r21","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41390-020-01342-0","article-title":"Validity of the Warner Initial Developmental Evaluation of Adaptive and Functional Skills (WIDEA-FS): a daily activity criterion checklist for infants and toddlers.","volume":"90","author":"Peyton","year":"2021","journal-title":"Pediatr Res"},{"issue":"2","key":"poi260044r22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa2119660","article-title":"Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns.","volume":"387","author":"Wu","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"poi260044r23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/pr.2017.15","article-title":"High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia.","volume":"81","author":"Frymoyer","year":"2017","journal-title":"Pediatr Res"},{"issue":"1","key":"poi260044r24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41390-024-03709-z","article-title":"On target dosing: erythropoietin exposure in neonates with hypoxic-ischemic encephalopathy in the HEAL trial.","volume":"98","author":"Frymoyer","year":"2025","journal-title":"Pediatr Res"},{"issue":"4","key":"poi260044r25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1203\/pdr.0b013e3180332cec","article-title":"A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats.","volume":"61","author":"Kellert","year":"2007","journal-title":"Pediatr Res"},{"issue":"3","key":"poi260044r26","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab172","article-title":"Recombinant erythropoietin does not augment hypothermic white matter protection after global cerebral ischaemia in near-term fetal sheep.","volume":"3","author":"Wassink","year":"2021","journal-title":"Brain Commun"},{"issue":"7","key":"poi260044r27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/children12070892","article-title":"Strategy to identify infants with hypoxic ischemic encephalopathy for therapeutic hypothermia-a retrospective audit.","volume":"12","author":"Haakons","year":"2025","journal-title":"Children (Basel)"},{"key":"poi260044r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2025.114522","article-title":"Prediction of 18 to 22 month neurodevelopmental outcomes using the numerical Sarnat Score compared with modified Sarnat staging in infants with moderate to severe hypoxic-ischemic encephalopathy.","volume":"281","author":"Natarajan","year":"2025","journal-title":"J Pediatr"},{"key":"poi260044r2","unstructured":"Chow? SSW, Creighton? P, Holberton? JR, Chambers? GM, Lui? K. Report of the Australian and New Zealand Neonatal Network 2022. Accessed January 23, 2026. http:\/\/www.anznn.net"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2851910\/jamapediatrics_liley_2026_oi_260044_1790892871.69701.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:00:51Z","timestamp":1791212451000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2851910"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.3082","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}